LYMPHOMA, FOLLICULAR

This phase 2 trial is testing a new combination of drugs, golcadomide and rituximab, in 90 people with newly diagnosed advanced follicular lymphoma. The goal is to see if this combination can improve complete remission rates compared to standard treatments. The study is active bu…

This study monitors the safety of the drug tazemetostat in 145 people with a type of lymphoma (follicular lymphoma) that has come back or not responded to treatment and has a specific gene change (EZH2 mutation). Researchers are tracking side effects and serious reactions during …

This study tests a combination of two drugs, mosunetuzumab and polatuzumab vedotin, in people with untreated follicular lymphoma. The drugs work together to help the immune system find and kill cancer cells. The goal is to see how many patients achieve a complete response, meanin…

This phase 3 trial tests whether adding lenalidomide to rituximab maintenance therapy works better than rituximab alone for people with relapsed follicular lymphoma who cannot have a stem cell transplant. About 128 participants will receive either the combination or rituximab alo…

This study follows 50 people who have already received an experimental CAR T cell therapy for certain blood cancers like lymphoma. No new treatment is given; instead, researchers will check for long-term side effects and how well the therapy works over 15 years. The goal is to be…